(RIGL) Rigel Pharmaceuticals - Performance 84% in 12m
Compare RIGL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-2.32%
#38 in Group
Rel. Strength
92.84%
#571 in Universe
Total Return 12m
84.02%
#18 in Group
Total Return 5y
-1.21%
#41 in Group
P/E 18.9
64th Percentile in Group
P/E Forward 22.2
71th Percentile in Group
PEG -0.10
50th Percentile in Group
FCF Yield 9.91%
87th Percentile in Group
12m Total Return: RIGL (84%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: RIGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RIGL
| Total Return (including Dividends) | RIGL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.75% | 2.02% | 2.87% |
| 3 Months | -12.53% | -15.44% | -6.42% |
| 12 Months | 84.02% | -14.02% | 9.87% |
| 5 Years | -1.21% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | RIGL | XBI | S&P 500 |
| 1 Month | 68.2% | 57% | 89.4% |
| 3 Months | -73.4% | -82.3% | -72% |
| 12 Months | 80.8% | -53.1% | 49.3% |
| 5 Years | -60.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #97 | 6.60% | 5.72% |
| 3 Month | #76 | 3.43% | -6.54% |
| 12 Month | #19 | 114% | 67.5% |
| 5 Years | #41 | 34.4% | -52.4% |
FAQs
Does RIGL Rigel Pharmaceuticals outperforms the market?
Yes,
over the last 12 months RIGL made 84.02%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months RIGL made -12.53%, while XBI made -15.44%.
Over the last 3 months RIGL made -12.53%, while XBI made -15.44%.
Performance Comparison RIGL vs Indeces and Sectors
RIGL vs. Indices RIGL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.62% | 5.88% | -19.6% | 74.2% |
| US NASDAQ 100 | QQQ | -2.87% | 4.04% | -20.0% | 72.7% |
| US Dow Jones Industrial 30 | DIA | -2.90% | 7.14% | -18.6% | 77.7% |
| German DAX 40 | DAX | -4.74% | -10.5% | -45.2% | 58.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.28% | 2.48% | -18.9% | 78.4% |
| Hongkong Hang Seng | HSI | -6.14% | -7.46% | -29.1% | 71.9% |
| India NIFTY 50 | INDA | -0.23% | 6.47% | -21.5% | 81.7% |
| Brasil Bovespa | EWZ | -4.67% | -2.78% | -28.8% | 90.5% |
RIGL vs. Sectors RIGL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.80% | 5.08% | -25.8% | 63.7% |
| Consumer Discretionary | XLY | -3.54% | 5.24% | -17.4% | 70.0% |
| Consumer Staples | XLP | -2.25% | 6.73% | -26.5% | 76.5% |
| Energy | XLE | -3.60% | 8.67% | -13.6% | 93.8% |
| Financial | XLF | -3.25% | 3.18% | -25.5% | 62.5% |
| Health Care | XLV | 1.17% | 13.1% | -14.4% | 89.9% |
| Industrial | XLI | -4.19% | 1.37% | -20.6% | 74.0% |
| Materials | XLB | -2.61% | 4.04% | -15.6% | 90.1% |
| Real Estate | XLRE | -2.29% | 2.63% | -22.0% | 70.6% |
| Technology | XLK | -3.51% | 2.01% | -17.4% | 77.0% |
| Utilities | XLU | -3.66% | 3.13% | -27.4% | 68.1% |
| Aerospace & Defense | XAR | -3.13% | -0.59% | -28.9% | 58.9% |
| Biotech | XBI | 5.46% | 6.73% | 1.44% | 98.0% |
| Homebuilder | XHB | -2.18% | 5.68% | -5.99% | 93.8% |
| Retail | XRT | -2.77% | 5.16% | -13.3% | 88.3% |